Linked Life Data

18528731

Source:http://linkedlifedata.com/resource/pubmed/id/18528731

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-6-19
pubmed:abstractText
The purpose of this study was to evaluate the predictive value of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography (FDG-PET) following concurrent chemoradiotherapy (CRT) on survival in patients with carcinoma of the oropharynx (OPC).
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-10655437, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-11232954, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-11796235, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-12115349, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-12115386, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-12578453, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-15386332, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-15611393, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-15627258, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-15695042, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-16160644, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-16172571, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-16391182, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17103167, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17237035, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17306956, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17391904, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17438244, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17475963, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-17761982, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-8417385, http://linkedlifedata.com/resource/pubmed/commentcorrection/18528731-9339990
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1536-1632
pubmed:author
pubmed:issnType
Print
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
224-9
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:18528731-Aged, pubmed-meshheading:18528731-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:18528731-Carcinoma, Squamous Cell, pubmed-meshheading:18528731-Cisplatin, pubmed-meshheading:18528731-Combined Modality Therapy, pubmed-meshheading:18528731-Disease-Free Survival, pubmed-meshheading:18528731-Drug Administration Schedule, pubmed-meshheading:18528731-Female, pubmed-meshheading:18528731-Fluorodeoxyglucose F18, pubmed-meshheading:18528731-Fluorouracil, pubmed-meshheading:18528731-Follow-Up Studies, pubmed-meshheading:18528731-Humans, pubmed-meshheading:18528731-Male, pubmed-meshheading:18528731-Middle Aged, pubmed-meshheading:18528731-Oropharyngeal Neoplasms, pubmed-meshheading:18528731-Positron-Emission Tomography, pubmed-meshheading:18528731-Predictive Value of Tests, pubmed-meshheading:18528731-Prognosis, pubmed-meshheading:18528731-Radiopharmaceuticals, pubmed-meshheading:18528731-Radiotherapy, Adjuvant, pubmed-meshheading:18528731-Survival Analysis, pubmed-meshheading:18528731-Taxoids
pubmed:articleTitle
Prognostic Value of FDG-PET in patients with oropharyngeal carcinoma treated with concurrent chemoradiotherapy.
pubmed:affiliation
Department of Otolaryngology, Osaka University School of Medicine, 2-2, Yamadaoka, Suita, Osaka, 565-0871, Japan. keisuke.enomoto@tracer.med.osaka-u.ac.jp
pubmed:publicationType
Journal Article, Comparative Study, Evaluation Studies